Medicine detail

Bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate

Used for: BIKTARVY is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 14 kg: who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically-suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen with no known or suspected substitutions associated with resistance to bictegravir or tenofovir.

Official label medicine Official label use ID 7865
bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate reference image: A weekly medication organizer with capsules.
Image: Pilulier semainier.JPG by Stephane8888, CC BY-SA 2.5.
What It Is Used For

Used for: BIKTARVY is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 14 kg: who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically-suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen with no known or suspected substitutions associated with resistance to bictegravir or tenofovir.

Active Ingredient

BICTEGRAVIR SODIUM, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE

Chemical Name

BICTEGRAVIR SODIUM, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE

Common Brands

Biktarvy

Generic / Alternate Names

BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE

Tracking Note

Use this entry as a reference/search starting point; verify dose, indication, and safety details with official labeling or a clinician.

Clinical links

Linked conditions and symptoms